Search

Daniel C. Gamett

Examiner (ID: 4072, Phone: (571)272-1853 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1647
Total Applications
1224
Issued Applications
721
Pending Applications
97
Abandoned Applications
422

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16282634 [patent_doc_number] => 20200276236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => REGULATORY MACROPHAGES FOR TREATING ANGIOPATHIES [patent_app_type] => utility [patent_app_number] => 16/647121 [patent_app_country] => US [patent_app_date] => 2018-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9400 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647121 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/647121
Regulatory macrophages for treating angiopathies Sep 11, 2018 Issued
Array ( [id] => 14072323 [patent_doc_number] => 20190085049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => Pulsed Introduction of Low-Dose RANKL as a Therapy for Diet-Induced Atherosclerosis [patent_app_type] => utility [patent_app_number] => 16/126821 [patent_app_country] => US [patent_app_date] => 2018-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/126821
Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclerosis Sep 9, 2018 Issued
Array ( [id] => 14102275 [patent_doc_number] => 20190092813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/125213 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125213 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/125213
Immunogenic WT-1 peptides and methods of use thereof Sep 6, 2018 Issued
Array ( [id] => 14016455 [patent_doc_number] => 20190070221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => Methods to Mobilize Tissue Resident Cells for Adoptive T Cell Therapy [patent_app_type] => utility [patent_app_number] => 16/123261 [patent_app_country] => US [patent_app_date] => 2018-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123261 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/123261
Methods to mobilize tissue resident cells for adoptive t cell therapy Sep 5, 2018 Issued
Array ( [id] => 14581301 [patent_doc_number] => 20190218259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => COMPOSITIONS AND METHODS FOR BROWN FAT INDUCTION AND ACTIVITY USING FNDC5 [patent_app_type] => utility [patent_app_number] => 16/121211 [patent_app_country] => US [patent_app_date] => 2018-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121211 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/121211
Compositions and methods for brown fat induction and activity using FNDC5 Sep 3, 2018 Issued
Array ( [id] => 13987095 [patent_doc_number] => 20190062705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES [patent_app_type] => utility [patent_app_number] => 16/118090 [patent_app_country] => US [patent_app_date] => 2018-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118090 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/118090
Methods for the production of therapeutic, diagnostic, or research antibodies Aug 29, 2018 Issued
Array ( [id] => 14102399 [patent_doc_number] => 20190092875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => DEPLETING TUMOR-SPECIFIC TREGS [patent_app_type] => utility [patent_app_number] => 16/116067 [patent_app_country] => US [patent_app_date] => 2018-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116067 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/116067
DEPLETING TUMOR-SPECIFIC TREGS Aug 28, 2018 Abandoned
Array ( [id] => 13982651 [patent_doc_number] => 20190060483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS [patent_app_type] => utility [patent_app_number] => 16/112547 [patent_app_country] => US [patent_app_date] => 2018-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25982 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112547 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/112547
Preparation of therapeutic exosomes using membrane proteins Aug 23, 2018 Issued
Array ( [id] => 15980553 [patent_doc_number] => 10670597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => Methods and kits for monitoring membranous nephropathy [patent_app_type] => utility [patent_app_number] => 16/106141 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 16776 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/106141
Methods and kits for monitoring membranous nephropathy Aug 20, 2018 Issued
Array ( [id] => 13493091 [patent_doc_number] => 20180298088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY [patent_app_type] => utility [patent_app_number] => 16/012395 [patent_app_country] => US [patent_app_date] => 2018-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012395 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/012395
COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY Jun 18, 2018 Abandoned
Array ( [id] => 13618661 [patent_doc_number] => 20180360882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => Perispinal Perfusion by Administration of T regulatory Cells Alone or in Combination with Angiogenic Cell Therapies [patent_app_type] => utility [patent_app_number] => 16/009982 [patent_app_country] => US [patent_app_date] => 2018-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9259 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16009982 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/009982
Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies Jun 14, 2018 Issued
Array ( [id] => 13590023 [patent_doc_number] => 20180346560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => METHOD FOR MODULATING APPETITE [patent_app_type] => utility [patent_app_number] => 16/004519 [patent_app_country] => US [patent_app_date] => 2018-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004519 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/004519
METHOD FOR MODULATING APPETITE Jun 10, 2018 Abandoned
Array ( [id] => 15738415 [patent_doc_number] => 20200108095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 16/615997 [patent_app_country] => US [patent_app_date] => 2018-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615997 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615997
UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS May 28, 2018 Abandoned
Array ( [id] => 15144979 [patent_doc_number] => 20190350967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => COMPOSITIONS FOR TREATMENT OF ARTHRITIS [patent_app_type] => utility [patent_app_number] => 15/981057 [patent_app_country] => US [patent_app_date] => 2018-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981057 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/981057
Compositions for treatment of arthritis May 15, 2018 Issued
Array ( [id] => 17183822 [patent_doc_number] => 20210330707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => HIGHLY ACTIVE NK CELL AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/612091 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612091 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/612091
Highly active NK cell and use thereof May 10, 2018 Issued
Array ( [id] => 18384681 [patent_doc_number] => 11655453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Expansion of gd T cells, compositions, and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/610398 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 61 [patent_no_of_words] => 33314 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610398 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610398
Expansion of gd T cells, compositions, and methods of use thereof May 2, 2018 Issued
Array ( [id] => 13578761 [patent_doc_number] => 20180340929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => TREATMENT OF INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 15/964324 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964324 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/964324
TREATMENT OF INFLAMMATORY DISEASES Apr 26, 2018 Abandoned
Array ( [id] => 13522111 [patent_doc_number] => 20180312598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => HUMAN TNFRSF25 ANTIBODY [patent_app_type] => utility [patent_app_number] => 15/964770 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10897 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964770 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/964770
Human TNFRSF25 antibody Apr 26, 2018 Issued
Array ( [id] => 13522113 [patent_doc_number] => 20180312599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => ANTI-TNFRSF25 ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/964775 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964775 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/964775
Anti-TNFRSF25 antibodies Apr 26, 2018 Issued
Array ( [id] => 14134293 [patent_doc_number] => 20190101536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-04 [patent_title] => CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY [patent_app_type] => utility [patent_app_number] => 15/962988 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962988 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/962988
CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY Apr 24, 2018 Abandoned
Menu